{"id":"W2982865643","doi":"10.1016/s1470-2045(19)30668-0","title":"Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Roche; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Docetaxel; Medicine; Ramucirumab; Clinical endpoint; Internal medicine; Metastatic Urothelial Carcinoma; Population; Oncology; Placebo; Progression-free survival; Surgery; Clinical trial; Chemotherapy; Cancer; Urothelial carcinoma; Bladder cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007785998,0.0004665293,0.001868829,0.0001773456,0.00005760202,0.00002364683,0.0002508274,0.0001824052,0.0003018766],"category_scores_gemma":[0.00008394589,0.0002640651,0.0001390949,0.0003203748,0.0002552227,0.0001278145,0.00005246023,0.0004285753,0.00001792957],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00040006,"about_ca_system_score_gemma":0.001532333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004700047,"about_ca_topic_score_gemma":0.0006998415,"domain_scores_codex":[0.9968677,0.0005384655,0.0008101468,0.0006108261,0.0005504559,0.0006223989],"domain_scores_gemma":[0.9976965,0.0007928398,0.000457112,0.0007014297,0.0001917429,0.0001603938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9900825,0.001461879,0.002949094,0.00009338162,0.0005890677,0.0001273222,0.000865245,0.0002695794,0.00008768275,0.00002127127,0.0001054377,0.003347553],"study_design_scores_gemma":[0.9626059,0.02830674,0.005913953,0.00009513296,0.0004505437,0.00000953751,0.0001165396,0.0004552579,0.0003522392,0.00001571236,0.001389996,0.0002884329],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863064,0.00028254,0.00005202714,0.0007148662,0.0006397036,0.009751482,0.0003896804,0.00004530718,0.001817997],"genre_scores_gemma":[0.9971592,0.00007692796,0.0005325208,0.0005673018,0.0002401511,0.0007589902,0.0002329011,0.00006400637,0.0003679568],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02747657,"threshold_uncertainty_score":0.9999812,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0584573287324271,"score_gpt":0.3466840245943807,"score_spread":0.2882266958619536,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}